Spinal Cord Stimulation vs. Medical Management for Lower Back Pain
Recruiting in Palo Alto (17 mi)
+31 other locations
Overseen byJames Yue, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Abbott Medical Devices
No Placebo Group
Approved in 3 Jurisdictions
Trial Summary
What is the purpose of this trial?
This trial is testing BurstDR SCS, a therapy that uses electrical pulses to reduce pain by stimulating the spinal cord. It targets patients with chronic low back pain who haven't found relief from other treatments and can't undergo surgery. The electrical pulses help block pain signals from reaching the brain. BurstDR SCS is a new type of stimulation that has shown better results compared to older methods in treating chronic pain.
Eligibility Criteria
This trial is for adults over 18 with chronic low back pain lasting at least 6 months, which hasn't improved after standard treatments and isn't suitable for surgery. Participants should have a pain score of ≥6 and disability index of ≥30%, be eligible for spinal cord stimulation, and not have had previous spine surgeries or conditions that could explain their pain.Inclusion Criteria
Patient must be willing and able to provide written informed consent prior to any clinical investigation-related procedure
Age ≥ 18 years
Willing and able to comply with the instructions for use, operate the study device, and comply with this Clinical Investigation Plan
See 6 more
Exclusion Criteria
You have a problem with your nerves that affects your ability to move your foot.
You have back pain caused by a tumor or cancer spreading to the spine.
You have widespread pain, like fibromyalgia, or pain in areas that are not the focus of this study, like neck or shoulder pain.
See 26 more
Treatment Details
Interventions
- Comprehensive Medical Management (Other)
- Conventional Medical Management (Other)
- Spinal Cord Stimulation (Spinal Cord Stimulation)
Trial OverviewThe study compares BurstDR spinal cord stimulation to conventional medical management in improving pain and physical function in patients with chronic axial low back pain with neuropathic characteristics who are not candidates for lumbar spine surgery.
Participant Groups
2Treatment groups
Active Control
Group I: Spinal Cord Stimulation (SCS)Active Control1 Intervention
An SCS Trial period followed by SCS Implantation with the Abbott Proclaim XR Implantable Pulse Generator
Group II: Conventional Medical Management (CMM)Active Control1 Intervention
CMM consists of an array of therapies including, but not limited to structured physical therapy, medications, injections, and complementary and alternative medicine (e.g. acupuncture, massage therapy)
Spinal Cord Stimulation is already approved in United States, European Union, Canada for the following indications:
🇺🇸 Approved in United States as Spinal Cord Stimulation for:
- Failed back surgery syndrome (FBSS)
- Adhesive arachnoiditis
- Peripheral causalgia/neuropathy
- Reflex sympathetic dystrophy (RSD)
- Phantom limb/stump pain
- Ischemic pain of vascular origin
- Complex regional pain syndrome
- Pain after an amputation
- Visceral abdominal pain and perineal pain
🇪🇺 Approved in European Union as Spinal Cord Stimulation for:
- Chronic pain
- Neuropathic pain
- Spinal cord injury pain
- Failed back surgery syndrome (FBSS)
- Adhesive arachnoiditis
- Peripheral causalgia/neuropathy
- Reflex sympathetic dystrophy (RSD)
🇨🇦 Approved in Canada as Spinal Cord Stimulation for:
- Chronic pain
- Neuropathic pain
- Spinal cord injury pain
- Failed back surgery syndrome (FBSS)
- Adhesive arachnoiditis
- Peripheral causalgia/neuropathy
- Reflex sympathetic dystrophy (RSD)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Connecticut Orthopedic SpecialistsHamden, CT
Coastal Pain & Spinal Diagnostics Medical GroupCarlsbad, CA
Summit SpinePortland, OR
The Orthopedic InstituteGainesville, FL
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Abbott Medical DevicesLead Sponsor